The genetic landscape of substance use disorders

ZF Gerring, JG Thorp, JL Treur, KJH Verweij… - Molecular …, 2024 - nature.com
Substance use disorders represent a significant public health concern with considerable
socioeconomic implications worldwide. Twin and family-based studies have long …

Considerations for the application of polygenic scores to clinical care of individuals with substance use disorders

RL Kember, CN Davis, KL Feuer, HR Kranzler - The Journal of Clinical …, 2024 - jci.org
Substance use disorders (SUDs) are highly prevalent and associated with excess morbidity,
mortality, and economic costs. Thus, there is considerable interest in the early identification …

The relationship between alcohol-and sleep-related traits: results from polygenic risk score and Mendelian randomization analyses

S Chakravorty, RL Kember, DR Mazzotti… - Drug and Alcohol …, 2023 - Elsevier
Study objectives We investigated whether genetic risk for insomnia and sleep duration
abnormalities are associated with AUD and alcohol consumption. We also evaluated the …

Next‐generation biomarkers for alcohol consumption and alcohol use disorder diagnosis, prognosis, and treatment: A critical review

SL Clark, EE Hartwell, DS Choi… - Alcohol: Clinical and …, 2024 - Wiley Online Library
This critical review summarizes the current state of omics‐based biomarkers in the alcohol
research field. We first provide definitions and background information on alcohol and …

Predicting Heterogeneity in Patient Response to Morphine Treatment for Neonatal Opioid Withdrawal Syndrome

D Smolyak, EM Humphries, A Parikh… - Clinical …, 2023 - Wiley Online Library
Infants with neonatal opioid withdrawal syndrome commonly receive morphine treatment to
manage their withdrawal signs. However, the effectiveness of this pharmacotherapy in …